Curcumin (Diferuloylmethane), Lipooxygenase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Curcumin (Diferuloylmethane), Lipooxygenase inhibitor (AB120618)
ab32137 staining c-Jun in HeLa cells treated with curcumin (diferuloylmethane) (ab120618), by ICC/IF. Decrease in c-Jun expression correlates with increased concentration of curcumin (diferuloylmethane) as described in literature.
The cells were incubated at 37°C for 4h in media containing different concentrations of ab120618 (curcumin (diferuloylmethane)) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab32137 (1/100 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- Chemical Structure
Lab
Chemical Structure - Curcumin (Diferuloylmethane), Lipooxygenase inhibitor (AB120618)
2D chemical structure image of ab120618, Curcumin (Diferuloylmethane), Lipooxygenase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
PloS one 11:e0163260 PubMed27644036
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com